David M Gunn, Age 52Asheville, NC

David Gunn Phones & Addresses

Asheville, NC

Hendersonville, NC

Horse Shoe, NC

9828 Dardanelle Ct, Las Vegas, NV 89117

7780 Somerhill Point Way, Las Vegas, NV 89139

Fairfield, CT

Reno, NV

Houston, TX

Show more

Work

Company: Seawane country club May 2013 Position: Assistant- in-training/second assistant

Education

School / High School: University of Connecticut- Storrs, CT May 2013 Specialities: Bachelor of Science in Turfgrass and Soil Science

Mentions for David M Gunn

Career records & work history

Lawyers & Attorneys

David Gunn Photo 1

David Gunn - Lawyer

ISLN:
921803117
Admitted:
1986
David Gunn Photo 2

David Gunn - Lawyer

ISLN:
911659274
Admitted:
1981

Medicine Doctors

David B. Gunn

Specialties:
Family Medicine
Work:
University Of California Los Angeles Health Porter Ranch
19950 Rinaldi St STE 300, Porter Ranch, CA 91326
(818) 271-2400 (phone) (818) 271-2401 (fax)
Conditions:
Abnormal Vaginal Bleeding, Anxiety Phobic Disorders, Bronchial Asthma, Constipation, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Hypertension (HTN), Hypothyroidism, Psoriasis, Substance Abuse and/or Dependency
Languages:
English
Description:
Dr. Gunn works in Porter Ranch, CA and specializes in Family Medicine.

License Records

David D Gunn

Licenses:
License #: E079146 - Active
Category: Emergency medical services
Issued Date: Jan 12, 2010
Expiration Date: Feb 28, 2019
Type: California Department of Parks and Recreation

David Gunn resumes & CV records

Resumes

David Gunn Photo 54

Engineer 3

Position:
Sr. Test Engineer at Aircell
Location:
Broomfield, Colorado
Industry:
Telecommunications
Work:
Aircell - Broomfield, CO since Nov 2010
Sr. Test Engineer
Sunrise Avionics Inc. D.B.A. SAI Technology Jul 2009 - Nov 2009
Hardware Test Development Engineer
Motorola ECC (sold to Emerson) Aug 2007 - Jan 2009
Product Engineer
Patchlink 2004 - 2004
Patch engineer
Sun Microsystems Jun 1999 - Nov 2001
SSE3
Cendant corp Aug 1998 - Jun 1999
UNIX systems administrator
Sun Microsystems - Mountain View & Menlo Park, Ca Feb 1987 - Jul 1996
Engineering Tech/ Lab manager
Skills:
Shell Scripting, Solaris, Labview, Word, Trouble shooting, Design debug, Visio, Debugging, Troubleshooting, Testing, Microsoft Word, Electronics, Embedded Systems, Engineering, Perl, Agile Methodologies, Unix
Interests:
Mechanical things, music, computers, electronics, reading, and being outside.
Honor & Awards:
Team Work award (2x) at Sun Microsystems Customer First award at Sun Microsystems Numerous atta-boys for innovative solutions at several companies.
David Gunn Photo 55

David Gunn

David Gunn Photo 56

David Gunn

David Gunn Photo 57

David Gunn

David Gunn Photo 58

David Gunn

David Gunn Photo 59

David Elizabeth Gunn

David Gunn Photo 60

Lead Personal Service Coodinator

Work:

Lead Personal Service Coodinator
David Gunn Photo 61

David Gunn

Publications & IP owners

Us Patents

Inhibition Of P38 Kinase Activity By Aryl Ureas

US Patent:
6344476, Feb 5, 2002
Filed:
May 22, 1998
Appl. No.:
09/083396
Inventors:
Gerald Ranges - Hamden CT
William Scott - Guilford CT
Michael Bombara - Hamden CT
Deborah Rauner - Sandy Hook CT
Aniko Redman - Derby CT
Roger Smith - Madison CT
Holger Paulsen - Wuppertal, DE
David Gunn - Hamden CT
Jinshan Chen - Hamden CT
Joel Renick - West Haven CT
Assignee:
Bayer Corporation - Pittsburgh PA
International Classification:
A61K 3138
US Classification:
514447, 514439, 514461, 514588, 514596
Abstract:
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

17-Beta-Hydroxysteroid Dehydrogenase-Ii Inhibitors

US Patent:
6784167, Aug 31, 2004
Filed:
Sep 28, 2001
Appl. No.:
09/967430
Inventors:
Jill E. Wood - North Haven CT
Jeremy L. Baryza - Mountain View CA
Catherine R. Brennan - Hamden CT
Soongyu Choi - Trumbull CT
James H. Cook - East Hampton CT
Brian R. Dixon - Woodbridge CT
Paul P. Ehrlich - Duesseldorf-Wittlaer, DE
David E. Gunn - Hamden CT
Ian McAlexander - Pocatello ID
Peiying Liu - Madison CT
Derek B. Lowe - Hamden CT
William J. Scott - Guilford CT
Yamin Wang - Sandy Hook CT
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
A61K 3140
US Classification:
514 63, 5142278, 5142372, 51425401, 514274, 514314, 514343, 514365, 514411, 514414, 514422, 514424, 544 582, 544 587, 544 60, 544141, 544316, 544372, 546167, 5462784, 548204, 548205, 548406, 548450, 548468, 548517, 548518, 548525, 548526, 548527, 548551
Abstract:
17-beta-hydroxysteroid dehydrogenase-II inhibitors having the structural formula wherein the phenyl group labeled A and the group âC(R )(R )Y are oriented cis to each other; W represents O or S; R represents âH or optionally substituted â(C -C )alkyl; n represents 0 or an integer of 1-3; and R represents any of a variety of substituents on ring A. R generally represents âH but may be a bond terminating at the ortho position of ring A. Y represents fluorine, âOR , or âSR , and R represents âH, optionally substituted â(C -C )alkyl, optionally substituted -phenyl, optionally substituted â(C -C )alkyl-phenyl, or optionally substituted â(C -C )acyl. R represents any of a variety of groups as defined in the specification and claims, including heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, alkynyl, arylalkynyl, heteroarylalkynyl, aryl, and indolyl. Pharmaceutically acceptable salts and N-oxides of these materials are also included.

1,8-Naphthyridine Derivatives And Their Use To Treat Diabetes And Related Disorders

US Patent:
6900205, May 31, 2005
Filed:
Sep 23, 2002
Appl. No.:
10/253104
Inventors:
Yamin Wang - Sandy Hook CT, US
William H. Bullock - Easton CT, US
David E. Gunn - Hamden CT, US
Qingjie Liu - Milford CT, US
Sidney X. Liang - Bethany CT, US
Donglei Liu - West Haven CT, US
Steven R. Magnuson - Wallingford CT, US
Tindy Li - West Haven CT, US
Eric S. Mull - Guilford CT, US
Jill E. Wood - North Haven CT, US
Ning Qi - Hamden CT, US
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
A61K031/5375
C07D413/14
US Classification:
5142352, 544127, 544362, 546183, 51425304, 514299
Abstract:
The invention relates generally to naphthyridine derivatives of the formula wherein one of U, X, Y and Z is nitrogen and the others are C—R, where R is hydrogen or a substituent. More specifically, the invention relates to 1,8-naphthyridine derivatives and pharmaceutical compositions containing such derivatives. Methods of the invention comprise administration of a naphthyridine derivative of the invention for the treatment of diabetes and related disorders.

1,8 Naphthyridine Derivatives And Their Use To Treat Diabetes And Related Disorders

US Patent:
7109196, Sep 19, 2006
Filed:
Apr 28, 2004
Appl. No.:
10/834357
Inventors:
Yamin Wang - Sandy Hook CT, US
William H. Bullock - Easton CT, US
David E. Gunn - Hamden CT, US
Qingjie Liu - Orange CT, US
Sidney X. Liang - Bethany CT, US
Donglei Liu - West Haven CT, US
Steven R. Magnuson - Wallingford CT, US
Tindy Li - West Haven CT, US
Eric S. Mull - Guilford CT, US
Jill E. Wood - North Haven CT, US
Ning Qi - Hamden CT, US
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
A61K 31/5375
C07D 413/14
US Classification:
5142352, 544127, 544362, 546183, 51425304, 514299
Abstract:
The invention relates generally to naphthyridine derivatives of the formula.

Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas

US Patent:
7371763, May 13, 2008
Filed:
Jun 22, 2005
Appl. No.:
11/158048
Inventors:
Jacques Dumas - Orange CT, US
Bernd Riedl - Wuppertal, DE
Uday Khire - Hamden CT, US
Robert N. Sibley - North Haven CT, US
Holia Hatoum-Mokdad - Hamden CT, US
Mary-Katherine Monahan - Hamden CT, US
David E. Gunn - Hamden CT, US
Timotthy B. Lowinger - Nishinomiya, JP
William J. Scott - Guilford CT, US
Roger A. Smith - Madison CT, US
Jill E. Wood - Hamden CT, US
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
C07D 401/02
A61K 31/44
A61K 31/47
US Classification:
514310, 514313, 514332, 546143, 546159, 546255
Abstract:
The invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.

Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas

US Patent:
7928239, Apr 19, 2011
Filed:
Feb 7, 2001
Appl. No.:
09/777920
Inventors:
Jacques Dumas - Orange CT, US
Bernd Riedl - Wuppertal, DE
Uday Khire - Hamden CT, US
Jill E. Wood - Hamden CT, US
Robert N. Sibley - North Haven CT, US
Mary-Katherine Monahan - Hamden CT, US
Joel Renick - Milford CT, US
David E. Gunn - Hamden CT, US
Timothy B. Lowinger - Nishinomiya, JP
William J. Scott - Guilford CT, US
Roger A. Smith - Madison CT, US
Assignee:
Bayer Healthcare LLC - Tarrytown NY
International Classification:
C07D 401/02
A61K 31/44
A61K 31/47
US Classification:
546152, 546159, 546180, 546261, 546264, 5462774, 514277, 514299, 514311, 514312, 514313, 514314
Abstract:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions in such therapy.

Heteroaryl Ureas Containing Nitrogen Hetero-Atoms As P38 Kinase Inhibitors

US Patent:
2002006, May 30, 2002
Filed:
Apr 20, 2001
Appl. No.:
09/838286
Inventors:
Jacques Dumas - Orange CT, US
Bernd Riedl - Wuppertal, DE
Uday Khire - Hamden CT, US
Robert Sibley - North Haven CT, US
Holia Hatoum-Mokdad - Hamden CT, US
Mary-Katherine Monahan - Hamden CT, US
David Gunn - Hamden CT, US
Timotthy Lowinger - Nishinomiya City, JP
William Scott - Guilford CT, US
Roger Smith - Madison CT, US
Jill Wood - Hamden CT, US
Assignee:
BAYER CORPORATION
International Classification:
A61K031/506
A61K031/501
A61K031/497
A61K031/4725
A61K031/4709
US Classification:
514/310000, 514/313000, 514/336000, 514/337000, 514/252030, 514/252040, 514/255050, 514/256000
Abstract:
This invention relates to the use of a group of heteroaryl ureas containing nitrogen in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.

Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas

US Patent:
2003020, Nov 6, 2003
Filed:
Apr 19, 2002
Appl. No.:
10/125369
Inventors:
Jacques Dumas - Orange CT, US
Bernd Riedl - Wuppertal, DE
Uday Khire - Hamden CT, US
Robert Sibley - North Haven CT, US
Holia Hatoum-Mokdad - Hamden CT, US
Mary-Katherine Monahan - Hamden CT, US
David Gunn - Hamden CT, US
Timothy Lowinger - Nishinomiya City, JP
William Scott - Guilford CT, US
Roger Smith - Madison CT, US
Jill Wood - Hamden CT, US
Assignee:
BAYER CORPORATION - Pittsburgh PA
International Classification:
C 07D 4 1/02
A61K031/4709
A61K031/4439
US Classification:
514/307000, 514/313000, 546/159000, 546/143000, 514/310000, 514/336000, 546/268100
Abstract:
This invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.

Isbn (Books And Publications)

Death'S Head

Author:
David Gunn
ISBN #:
0345498275

Judges

Author:
David Gunn
ISBN #:
0631222510

Judges

Author:
David Gunn
ISBN #:
0631222529

Industrial Boilers

Author:
David Gunn
ISBN #:
0470210559

Poor Man'S Ray Gun

Author:
David Gunn
ISBN #:
0879471557

Narrative In The Hebrew Bible

Author:
David M. Gunn
ISBN #:
0192132458

Compromising Redemption: Relating Characters In The Book Of Ruth

Author:
David M. Gunn
ISBN #:
0664251358

Gender, Power, And Promise: The Subject Of The Bible'S First Story

Author:
David M. Gunn
ISBN #:
0687140420

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.